Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.57 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | RARB | P10826 | 4/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL20916139 | 0.98 | GAA (0.56) | GAANR1I2MAPK1L3MBTL1RARB | |
| SCHEMBL1302689 | 0.88 | GAA (0.56) | GAANR1I2MAPK1L3MBTL1RARB | |
| SCHEMBL29404503 | 0.88 | GAA (0.56) | GAANR1I2MAPK1L3MBTL1RARB | |
| SCHEMBL334685 | 0.86 | GAA (0.54) | GAANR1I2MAPK1L3MBTL1RARB | |
| SCHEMBL9378715 | 0.86 | TSHR (0.60) | GAAL3MBTL1RARBALDH1A1MEN1 | |
| SCHEMBL11680771 | 0.86 | L3MBTL1 (0.60) | MAPK1L3MBTL1MAPTALDH1A1MEN1 | |
| SCHEMBL28274164 | 0.85 | GAA (0.53) | GAANR1I2MAPK1L3MBTL1RARB | |
| SCHEMBL7909288 | 0.85 | RARB (0.63) | L3MBTL1RARB | |
| SCHEMBL7415359 | 0.84 | L3MBTL1 (0.53) | GAAMAPK1L3MBTL1RARBMAPT | |
| Water SCHEMBL20360651 | 0.84 | MAPK1 (0.45) | GAAMAPK1L3MBTL1RARBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 363 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024093647-A1 | THREE-DIMENSIONAL PRINTING METHODS FOR MAKING METAL-EMBEDDED MEDICAL IMPLANTS AND DEVICES | THE UNIVERSITY OF HONG KONG (CN) | 2024-05-10 | — | — | WO | claimed |
| EP-3727797-B1 | A HYBRID PHOTOPOLYMER COMPOSITION FOR ADDITIVE MANUFACTURING | PERSTORP AB (SE) | 2023-09-27 | — | — | EP | claimed |
| US-11130874-B2 | Hybrid photopolymer composition for additive manufacturing | PERSTORP AB (SE) | 2021-09-28 | — | — | US | claimed |
| US-20200308426-A1 | A HYBRID PHOTOPOLYMER COMPOSITION FOR ADDITIVE MANUFACTURING | PERSTORP AB (SE) | 2020-10-01 | — | — | US | claimed |
| EP-2558427-B1 | D1492 LIQUID BAPO PHOTOINITIATOR AND ITS USE IN RADIATION CURABLE COMPOSITIONS | DSM IP ASSETS BV (NL) | 2017-05-31 | — | — | EP | claimed |
| US-9114572-B2 | Method of post-mold crosslinking thermoplastic polyurethane golf ball cover compositions | NIKE, INC. (US) | 2015-08-25 | — | — | US | claimed |
| US-20140210142-A1 | Method of Post-Mold Crosslinking Thermoplastic Polyurethane Golf Ball Cover Compositions | NIKE, INC. (US) | 2014-07-31 | — | — | US | claimed |
| US-8633258-B2 | D1492 liquid BAPO photoinitiator and its use in radiation curable compositions | DSM IP ASSETS B.V. (NL) | 2014-01-21 | — | — | US | claimed |
| US-20130237626-A1 | D1479 STABLE LIQUID BAP PHOTOINITIATOR AND ITS USE IN RADIATION CURABLE COMPOSITIONS | DSM IP ASSETS B.V. (NL) | 2013-09-12 | — | — | US | claimed |
| WO-2012074931-A2 | PHOTOLINDUCED ALKYNE-AZIDE CLICK REACTIONS | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2012-06-07 | — | — | WO | claimed |
| US-6942824-B1 | UV curable and electrically conductive adhesive for bonding magnetic disk drive components | WESTERN DIGITAL (FREMONT), INC. (US) | 2005-09-13 | — | — | US | claimed |
| EP-0830641-B1 | PHOTOHARDENABLE EPOXY COMPOSITION | DSM NV (NL) | 2003-08-27 | — | — | EP | claimed |
| WO-2002096180-A1 | A RADIATION CURABLE PRIMARY COATING COMPOSITION FOR AN OPTICAL FIBER | ALVIN C. LEVY & ASSOCIATES, INC. (US) | 2002-12-05 | — | — | WO | claimed |
| EP-1012657-A4 | THERMALLY SWITCHABLE OPTICAL DEVICES | UNIV PITTSBURGH (US) | 2001-09-12 | — | — | EP | claimed |
| US-6165389-A | Thermally switchable optical devices | UNIVERSITY OF PITTSBURGH OF THE COMMONWEALTH OF HIGHER EDUCATION (US) | 2000-12-26 | — | — | US | claimed |
| EP-1012657-A1 | THERMALLY SWITCHABLE OPTICAL DEVICES | UNIVERSITY OF PITTSBURGH OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2000-06-28 | — | — | EP | claimed |
| US-6042943-A | PROTECTIVE COATING FOR RELIEVING STRESS WHEN FIBER IS BENT, CABLED, AND SPOOLED | ALVIN C. LEVY & ASSOCIATES, INC. (US) | 2000-03-28 | — | — | US | claimed |
| US-5985952-A | CURABLE COATINGS FOR OPTICAL FIBERS WITH EPOXIDE GROUPS AND ACRYLATE MONOMERS | ALVIN C. LEVY & ASSOCIATES, INC. (US) | 1999-11-16 | — | — | US | claimed |
| WO-1998020388-A1 | THERMALLY SWITCHABLE OPTICAL DEVICES | UNIVERSITY OF PITTSBURGH OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 1998-05-14 | — | — | WO | claimed |
| US-5340620-A | Hydrosilation, adding photoinitiator, coating ultraviolet sensitive formulation onto a substrate, drying, and curing | INTERNATIONAL PAPER COMPANY (US) | 1994-08-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130237626-A1 | D1479 STABLE LIQUID BAP PHOTOINITIATOR AND ITS USE IN RADIATION CURABLE COMPOSITIONS | BAP1, CCNT1, RB1 | GAA 4721/4885NR1I2 1977/4885MAPK1 863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.